Crystal deal toy marking the sale of a royalty interest in OXLUMO. OXLUMO has been approved by both the Food and Drug Administration (FDA), and the European Medicine’s Agency (EMA).
(21ALJ215)
Crystal deal toy marking the sale of a royalty interest in OXLUMO. OXLUMO has been approved by both the Food and Drug Administration (FDA), and the European Medicine’s Agency (EMA).
(21ALJ215)